Profit Pro için 60%’ye varan indirim - İlk 500 kullanıcıya özel
Black Friday İndirimi

Profit Pro için 60% indirim - İlk 500 kullanıcıyla sınırlıdır

Pfizer Inc

Pfizer Inc

PFE · NYSE
PFE · NYSE

Sonraki Kazançlar: 28 Oca 2025

25.09
USD0.160.62%

Tarih

Ticker'lar

Başlık

Kaynak

    Pfizer names oncology chief and company veteran Boshoff as chief scientific officer

    MarketWatch

      Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

      MarketWatch

        Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company

        CNBC

          Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC

          CNBC

            FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC

            CNBC

              Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment

              MarketWatch

                Pfizer former executives exit activist drive (NYSE:PFE) - Seeking Alpha

                Seeking Alpha

                  Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says - CNBC

                  CNBC

                    Former Pfizer CEO, finance chief step back from Starboard's activist campaign - CNBC

                    CNBC

                      Pfizer wins bid to invalidate GSK's patents over RSV vaccine https://t.co/U4qDo7fLwQ https://t.co/1oT7s25ePe

                      Reuters
                      @Reuters

                        Activist investor Starboard has informed Pfizer it has taken a stake - Business Insider

                        Business Insider

                          Starboard reportedly takes $1 billion stake in Pfizer, seeks changes

                          MarketWatch

                            Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say - CNBC

                            CNBC

                              Activist Starboard takes $1B stake in Pfizer - WSJ

                              SeekingAlpha

                                Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer - The Wall Street Journal

                                The Wall Street Journal

                                  Pfizer yanks sickle-cell treatment worldwide after possible link to deaths

                                  MarketWatch

                                    Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results - CNBC

                                    CNBC

                                      Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine

                                      MarketWatch

                                        Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives

                                        MarketWatch

                                          Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness

                                          MarketWatch

                                            UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain https://t.co/p57xSfPA5r https://t.co/duJDOW0QcD

                                            Reuters
                                            @Reuters

                                              Pfizer announces positive results from late-stage trial of hemophilia A treatment

                                              MarketWatch

                                                Pfizer signals progress on obesity pill, boosting stock

                                                MarketWatch

                                                  Pfizer moves forward with once-daily version of weight loss pill after setbacks

                                                  CNBC

                                                    SEC blasts Pfizer's bid for $75 million from insider trading victims' fund https://t.co/zi2o5UQjRt https://t.co/oqYMmcJzfN

                                                    Reuters
                                                    @Reuters

                                                      Pfizer defends appellate court’s ‘naming names’ rule in lawsuit over diversity program https://t.co/AJ35cUGXng https://t.co/0EpfCJjqze

                                                      Reuters
                                                      @Reuters

                                                        UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case https://t.co/eCV2WLo1sb https://t.co/ant6wAXYMX

                                                        Reuters
                                                        @Reuters

                                                          Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline - CNBC

                                                          CNBC

                                                            Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster

                                                            MarketWatch

                                                              Pfizer's Duchenne gene therapy fails in late-stage study https://t.co/z9hCGWBuFv https://t.co/re9Wjf19vK

                                                              Reuters
                                                              @Reuters

                                                                Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds https://t.co/u3wDGUZL8s https://t.co/H7rNkEGC2s

                                                                Reuters
                                                                @Reuters

                                                                  Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

                                                                  CNBC

                                                                    Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK

                                                                    Reuters
                                                                    @Reuters

                                                                      Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot https://t.co/pu0pSdZbog https://t.co/gKLeO9j877

                                                                      Reuters
                                                                      @Reuters

                                                                        ⚠️ JUST IN: *PFIZER SAYS YOUNG BOY WHO GOT GENE THERAPY SUFFERED CARDIAC ARREST $PFE https://t.co/VXFOAflzIJ

                                                                        Investingcom
                                                                        @Investingcom

                                                                          Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC https://t.co/gRRWscbh4s https://t.co/01D983fx9G

                                                                          Reuters
                                                                          @Reuters

                                                                            Pfizer reports patient death in Duchenne gene therapy study https://t.co/4qCybBOOSL https://t.co/GfgTr3Dxvm

                                                                            Reuters
                                                                            @Reuters

                                                                              AI-Driven Drug Discovery by Pfizer and Austrian Institute Set to Transform Healthcare

                                                                              Cryptopolitan

                                                                                S&P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p

                                                                                Reuters
                                                                                @Reuters

                                                                                  Ex-Pfizer employee convicted of insider trading on COVID drug trial https://t.co/luI3r8Ww4b https://t.co/phN98DFyMs

                                                                                  Reuters
                                                                                  @Reuters

                                                                                    Former Pfizer employee goes down for insider trading in COVID drug trial

                                                                                    Cryptopolitan

                                                                                      Pfizer closes Seagen acquisition

                                                                                      SeekingAlpha

                                                                                        Pfizer shares fall as 2024 revenue and profit forecast disappoints

                                                                                        CNBC

                                                                                          Seagen gains amid options trades, optimism for FTC approval for Pfizer deal

                                                                                          SeekingAlpha

                                                                                            Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops - CNBC

                                                                                            CNBC

                                                                                              ⚠️BREAKING: *PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL $PFE https://t.co/5YVXZADCRj

                                                                                              Investingcom
                                                                                              @Investingcom

                                                                                                ⚠️BREAKING: *PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL $PFE https://t.co/SrVSxf8PwG

                                                                                                Investingcom
                                                                                                @Investingcom

                                                                                                  Pfizer pulls the plug on twice-daily obesity pill as study disappoints - Reuters

                                                                                                  Reuters

                                                                                                    Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects - CNBC

                                                                                                    CNBC

                                                                                                      Pfizer CFO reiterates Seagen closing expected later this year, early next year

                                                                                                      SeekingAlpha